Role of 25-hydroxyvitamin D in irritable bowel syndrome patients

J Family Med Prim Care. 2022 Dec;11(12):7975-7978. doi: 10.4103/jfmpc.jfmpc_1336_22. Epub 2023 Jan 17.

Abstract

We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up.

Keywords: Dyspepsia; Irritable bowel syndrome; vitamin D.

Publication types

  • Case Reports